EFFECTS OF HCFC-123 EXPOSURE TO MATERNAL AND INFANT RHESUS MONKEYS ON HEPATIC BIOCHEMISTRY, LACTATIONAL PARAMETERS AND POSTNATAL GROWTH

REFERENCES

• Gibson G., Lake B. Peroxisomes: Biology and Importance in Toxicology and Medicine, G. Gibson, B. Lake. Taylor and Francis, Washington, DC 1993
   Google Scholar
• Roberts R.A. Peroxisome Proliferators: Mechanisms of Adverse Effects in Rodents and Molecular Basis for Species Differences. Arch. Toxicol. 1999; 73: 413–418
   PubMed Web of Science ®Google Scholar
• Choudhury A.I., Chahal S., Bell A.R., Tomlinson S.R., Roberts R.A., Salter A.M., Bell D.R. Species Differences in Peroxisome Proliferation; Mechanisms and Relevance. Mut. Res. 2000; 448: 201–212
   PubMed Web of Science ®Google Scholar
• Carton J.C., Lapinskas P.L., Gonzalez F.J. Central Role of PPARα in the Mechanism of Action of Hepatocarcinogenic Peroxisome Proliferators. Mut. Res. 2000; 448: 139–151
   PubMed Web of Science ®Google Scholar
• Cattley R.C., DeLuca J., Elcombe C., Fenner-Crisp P., Lake B.G., Marsman D.S., Pastoor T.A., Popp J.A., Robinson D.E., Schwetz B., Tugwood J.D., Wahli W. Do Peroxisome Proliferating Compounds Pose a Hepatocarcinogenic Risk to Humans. Reg. Toxicol. Pharmacol. 1998; 27: 47–60
   Web of Science ®Google Scholar
• Bentley P., Calder I., Elcombe C., Grasso P., Stringer D., Wiegand H.J. Hepatic Peroxisome Proliferation in Rodents and Its Significance for Humans. Food. Chem. Toxicol. 1993; 31: 857–907
   PubMed Web of Science ®Google Scholar
• Rusch G.M., Trochimowicz H.J., Malley L.A., Kelly D.P., Peckham J., Hansen J., Harm J.B. Subchronic Inhalation Toxicity Studies with Hydrochlorofluorocarbon 123 (HCFC-123). Fund. Appl. Toxicol. 1994; 23: 169–178
   PubMedGoogle Scholar
• Malinverno G., Rusch G.M., Millischer R.J., Hughes E.W., Schroeder R.E., Coombs D.W. Inhalation Teratology and Reproduction Studies with 1,1-Dichloro-2,2,2-trifluorethane (HCFC-123). Fund. Appl. Toxicol. 1996; 34: 276–287
   PubMedGoogle Scholar
• Gibson J.P., Larson E.J., Yarrington J.T., Hook R.H., Kariya T., Blohm T.R. Toxicity and Teratogenicity Studies with the Hypolipidemic Drug RMI 14,514 in Rats. Fund. Appl. Toxicol. 1981; 1: 19–25
   PubMedGoogle Scholar
• Fitzgerald J.E., Petrere J.A., de la Iglesia F.A. Experimental Studies on Reproduction with Lipid-Regulating Agent Gemfibrozil. Fund. Appl. Toxicol. 1987; 8: 454–464
   PubMedGoogle Scholar
• Rusch G.M. Toxicological Evaluations of Alternative Fluorocarbons. Drug Chem. Toxicol. 2000; 23: 27–40
   PubMed Web of Science ®Google Scholar
• Lazarow P.B. Assay of Peroxisomal β-oxidation of Fatty Acids. Method. Enzymol. 1981; 72: 315–319
   PubMedGoogle Scholar
• Okita R.T., Chance C. Induction of Laurate w-Hydroxylase by di(2-Ethylhexyl)phthalate in Rat Liver Microsomes. Biochem. Biophysic. Res. Comm. 1984; 121: 304–309
   PubMed Web of Science ®Google Scholar
• Vinegar A., Williams R.J., Fisher J.W., McDougal J.N. Dose-Dependent Metabolism of 2,2-dichloro-1,1,1-trifuoroethane: A Physiology Based Pharmacokinetic Model in the Male Fischer 344 Rat. Toxicol. Appl. Pharmacol. 1994; 129: 103–113
   PubMed Web of Science ®Google Scholar
• Maiorino R.M., Gandolfi A.J., Sipes I.G. Gas-Chromatographic Method for the Halothane Metabolites, Trifluoracetic Acid and Bromide, in Biological Fluids. J. Analyt. Toxicol. 1980; 4: 250–254
   PubMed Web of Science ®Google Scholar
• Gargas M.L., Burgess R.A., Voisard D.E., Cason G.H., Anderson M.E. Partition Coefficients of Low-Molecular-Weight Volatile Chemicals in Various Liquids and Tissues. Toxicol. Appl. Pharmacol. 1989; 98: 87–99
   PubMed Web of Science ®Google Scholar
• Ashby J., Brady A., Elcombe C.R., Elliott B.M., Ishmael J., Odum J., Tugwood J.D., Kettle S., Purchase I.F.H. Mechanistically-Based Human Hazard Assessment of Peroxisome Proliferator-Induced Hepatocarcinogenesis. Hum. Exper. Tox. 1994; 13: Sl–S117
   Google Scholar
• Lake B.G. Peroxisome Proliferation: Current Mechanisms Relating to Non-genotoxic Carcinogens. Toxicol. Lett. 1995; 82/83: 673–681
   Web of Science ®Google Scholar
• Reddy J.K., Lalwani N.D., Qureshi S.A., Reddy M.K., Moehle C.M. Induction of Hepatic Peroxisome Proliferation in Nonrodent Species, Including Primates. Am. J. Pathol. 1984; 114: 171–183
   PubMed Web of Science ®Google Scholar
• Gray R.H., de la Iglesia F.A. Quantitative Microscopy Comparison of Peroxisome Proliferation by the Lipid-Regulating Agent Gemfibrozil in Several Species. Hepatology 1984; 4: 520–530
   PubMed Web of Science ®Google Scholar
• Palmer C.N.A., Hsu M.H., Griffin K.J., Raucy J.L., Johnson E.F. Peroxisome Proliferator Activated Receptor-α Expression in Human Liver. Mol. Pharmacol. 1998; 53: 14–22
   PubMed Web of Science ®Google Scholar
• Tugwood J.D., Holden P.R., James N.H., Prince R.A., Roberts R.A. A Peroxisome Proliferator-Activated Receptor-Alpha (PPARα) cDNA Cloned from Guinea-Pig Liver Encodes a Protein with Similar Properties to the Mouse PPARα: Implications for Species Differences in Responses to Peroxisome Proliferators. Arch. Toxicol. 1998; 72: 169–177
   PubMed Web of Science ®Google Scholar
• Malley L.A., Carakostas M., Hansen J.F., Rusch G.M., Kelly D.P., Trochimowicz H.J. Two-year Inhalation Toxicity Study in Rats with the Hydrochlorofluorocarbon 123. Fund. Appl. Toxicol. 1995; 25: 101–114
   PubMedGoogle Scholar
• Biegel L.A., Hurtt M.E., Frame S.R., Cook J.C. Mechanisms of Extrahepatic Tumor Induction by Peroxisome Proliferators in Male CD Rats. Toxicol. Sci. 2001; 60: 44–55
   PubMed Web of Science ®Google Scholar
• Orton T.C., Adam H.K., Bentley M., Holloway B., Tucker M.J. Clobuzarit: Species Differences in the Morphological and Biochemical Response of the Liver following Chronic Administration. Toxicol. Appl. Pharmacol. 1984; 73: 138–151
   PubMed Web of Science ®Google Scholar
• Biegel L.A., Hurtt M.E., Frame S.R., Applegate M., O'Connor J.C., Cook J.C. Comparison of the Effects of Wyeth-14,643 in CrI : CD BR Rats and Fisher-344 Rats. Fund. Appl. Toxicol. 1992; 19: 590–597
   PubMedGoogle Scholar
• Haughom B., Spydevold O. The Mechanism Underlying the Hypolipemic Effect of Perfluorooctanoic Acid (PFOA), Perfluorooctane Sulphonic Acid (PFOSA) and Clofibric Acid. Biochem. Biophys. Acta 1992; 1128: 65–72
   PubMed Web of Science ®Google Scholar
• Lind R.C., Gandolfi A.J., Hall P.M. Biotransformation and Hepatotoxicity of HCFC-123 in the Guinea Pig: Potentiation of Hepatic Injury by Prior Glutathione Depletion. Toxicol. Appl. Pharmacol. 1995; 134: 175–181
   PubMed Web of Science ®Google Scholar
• Nyitray M., Szaszovszky E., Druga A. Clofibrate and the Development of Rats. Arch. Toxicol. 1980; 4: 463–465
   Google Scholar
• Buschmann J., Bartsch W., Dasenbrock C.F., Fuhst R., Pohlmann G., Preib A., Berger-Preib E. Cross-Fostering Inhalation Toxicity Study with HCFC-123 in Lactating Sprague-Dawley Rats. Inhal. Toxicol. 2001; 13: 671–687
   PubMed Web of Science ®Google Scholar
• Capuzzi D.M., Lackman R.D., Alexander J., Intenzo C.M., Reed M.A. Rapid Modulation of Lipogenesis by Clofibrate in Rat and Monkey Hepatocytes. Biochem. Biophys. Acta 1975; 409: 144–155
   PubMed Web of Science ®Google Scholar
• Brandorff N.P. The Effects of Dietary Fat on the Fatty Acid Composition of Lipids Secreted in Rats' Milk. Lipids 1980; 15: 276–278
   PubMed Web of Science ®Google Scholar
• Galli C., Spagnuolo C. Essential Fatty Acids in Maternal Diet and in Rat Milk Phospholipids. Lipids 1974; 9: 1030–1032
   PubMed Web of Science ®Google Scholar
• Cappon G.D., Liu R.C., Frame S.R., Hurtt M.E. Effects of the Rat Hepatic Peroxisome Proliferator, Wyeth 14-643, on the Lactating Goat. Drug. Chem. Toxicol. 2002; 25: 255–266
   PubMed Web of Science ®Google Scholar